keyword
Keywords parkinson alzheimer stroke dys...

parkinson alzheimer stroke dystonia

https://read.qxmd.com/read/37373667/adult-onset-neuroepidemiology-in-finland-lessons-to-learn-and-work-to-do
#1
REVIEW
Jussi O T Sipilä
Finland is a relatively small genetic isolate with a genetically non-homogenous population. Available Finnish data on neuroepidemiology of adult-onset disorders are limited, and this paper describes the conclusions that can be drawn and their implications. Apparently, Finnish people have a (relatively) high risk of developing Unverricht-Lundborg disease (EPM1), Multiple Sclerosis (MS), Amyotrophic Lateral Sclerosis (ALS), Spinal muscular atrophy, Jokela type (SMAJ) and adult-onset dystonia. On the other hand, some disorders, such as Friedreich's ataxia (FRDA) and Wilson's disease (WD), are almost absent or completely absent in the population...
June 11, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/36507340/movement-related-beta-erd-and-ers-abnormalities-in-neuropsychiatric-disorders
#2
REVIEW
Jaime Peter, Francesca Ferraioli, Dave Mathew, Shaina George, Cameron Chan, Tomisin Alalade, Sheilla A Salcedo, Shannon Saed, Elisa Tatti, Angelo Quartarone, M Felice Ghilardi
Movement-related oscillations in the beta range (from 13 to 30 Hz) have been observed over sensorimotor areas with power decrease (i.e., event-related desynchronization, ERD) during motor planning and execution followed by an increase (i.e., event-related synchronization, ERS) after the movement's end. These phenomena occur during active, passive, imaged, and observed movements. Several electrophysiology studies have used beta ERD and ERS as functional indices of sensorimotor integrity, primarily in diseases affecting the motor system...
2022: Frontiers in Neuroscience
https://read.qxmd.com/read/35956919/insights-into-the-explicit-protective-activity-of-herbals-in-management-of-neurodegenerative-and-cerebrovascular-disorders
#3
REVIEW
Tapan Behl, Rashita Makkar, Aayush Sehgal, Neelam Sharma, Sukhbir Singh, Mohammed Albratty, Asim Najmi, Abdulkarim M Meraya, Simona Gabriela Bungau
The longstanding progressive neurodegenerative conditions of the central nervous system arise mainly due to deterioration, degradation and eventual neuronal cell loss. As an individual ages, the irreversible neurodegenerative disorders associated with aging also begin to develop, and these have become exceedingly prominent and pose a significant burden mentally, socially and economically on both the individual and their family. These disorders express several symptoms, such as tremors, dystonia, loss of cognitive functions, impairment of motor activity leading to immobility, loss of memory and many more which worsen with time...
August 4, 2022: Molecules: a Journal of Synthetic Chemistry and Natural Product Chemistry
https://read.qxmd.com/read/32417703/human-brain-connectivity-clinical-applications-for-clinical-neurophysiology
#4
REVIEW
Mark Hallett, Willem de Haan, Gustavo Deco, Reinhard Dengler, Riccardo Di Iorio, Cecile Gallea, Christian Gerloff, Christian Grefkes, Rick C Helmich, Morten L Kringelbach, Francesca Miraglia, Ivan Rektor, Ondřej Strýček, Fabrizio Vecchio, Lukas J Volz, Tao Wu, Paolo M Rossini
This manuscript is the second part of a two-part description of the current status of understanding of the network function of the brain in health and disease. We start with the concept that brain function can be understood only by understanding its networks, how and why information flows in the brain. The first manuscript dealt with methods for network analysis, and the current manuscript focuses on the use of these methods to understand a wide variety of neurological and psychiatric disorders. Disorders considered are neurodegenerative disorders, such as Alzheimer disease and amyotrophic lateral sclerosis, stroke, movement disorders, including essential tremor, Parkinson disease, dystonia and apraxia, epilepsy, psychiatric disorders such as schizophrenia, and phantom limb pain...
July 2020: Clinical Neurophysiology: Official Journal of the International Federation of Clinical Neurophysiology
https://read.qxmd.com/read/31194694/can-neuromodulation-techniques-optimally-exploit-cerebello-thalamo-cortical-circuit-properties-to-enhance-motor-learning-post-stroke
#5
REVIEW
Sharon Israely, Gerry Leisman
Individuals post-stroke sustain motor deficits years after the stroke. Despite recent advancements in the applications of non-invasive brain stimulation techniques and Deep Brain Stimulation in humans, there is a lack of evidence supporting their use for rehabilitation after brain lesions. Non-invasive brain stimulation is already in use for treating motor deficits in individuals with Parkinson's disease and post-stroke. Deep Brain Stimulation has become an established treatment for individuals with movement disorders, such as Parkinson's disease, essential tremor, epilepsy, cerebral palsy and dystonia...
November 26, 2019: Reviews in the Neurosciences
https://read.qxmd.com/read/27865707/a-comprehensive-database-of-published-tdcs-clinical-trials-2005-2016
#6
REVIEW
Jean-Pascal Lefaucheur
Transcranial direct current stimulation (tDCS) is a technique of noninvasive cortical stimulation allowing significant modification of brain functions. Clinical application of this technique was reported for the first time in March 2005. This paper presents a detailed list of the 340 articles (excluding single case reports) which have assessed the clinical effect of tDCS in patients, at least when delivered to cortical targets. The reviewed conditions were: pain syndromes, Parkinson's disease, dystonia, cerebral palsy, post-stroke limb motor impairment, post-stroke neglect, post-stroke dysphagia, post-stroke aphasia, primary progressive aphasia, multiple sclerosis, epilepsy, consciousness disorders, Alzheimer's disease and other types of dementia, tinnitus, depression, auditory hallucinations and negative symptoms of schizophrenia, addiction and craving, autism, and attention disorders...
December 2016: Clinical Neurophysiology
https://read.qxmd.com/read/27403908/-evaluation-of-repetitive-transcranial-magnetic-stimulation-effectiveness-in-treatment-of-psychiatric-and-neurologic-diseases
#7
REVIEW
Żanna Pastuszak, Anna Stępień, Renata Piusińska-Macoch, Bogdan Brodacki, Kazimierz Tomczykiewicz
Repetitive transcranial magnetic stimulation (rTMS) is a treatment option with proved effectiveness especially in drug resist depression. It is used in functional brain mapping before neurosurgery operations and diagnostic of corticospinal tract transmission. Many studies are performed to evaluate rTMS using in treatment of obsessive - compulsive disorder, schizophrenia, autism, strokes, tinnitus, Alzheimer and Parkinson diseases, cranial traumas. Moreover rTMS was used in treatment of multiple sclerosis, migraine, dystonia...
June 2016: Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego
https://read.qxmd.com/read/26153456/depression-a-common-disorder-across-a-broad-spectrum-of-neurological-conditions-a-cross-sectional-nationally-representative-survey
#8
JOURNAL ARTICLE
Andrew G M Bulloch, Kirsten M Fiest, Jeanne V A Williams, Dina H Lavorato, Sandra A Berzins, Nathalie Jetté, Tamara M Pringsheim, Scott B Patten
OBJECTIVE: To estimate the prevalence of depression across a range of neurological conditions in a nationally representative sample. METHODS: The data source was the Survey of Living with Neurological Conditions in Canada (SLNCC), which accrued its sample by selecting participants from the Canadian Community Health Survey. The point prevalence of depression was estimated by assessment of depressive symptoms with the Patient Health Questionnaire, Brief (Patient Health Questionnaire, 9-item)...
November 2015: General Hospital Psychiatry
https://read.qxmd.com/read/25658681/alexithymia-in-neurological-disease-a-review
#9
REVIEW
Lucia Ricciardi, Benedetta Demartini, Aikaterini Fotopoulou, Mark J Edwards
OBJECTIVE: Alexithymia has been considered a personality trait characterized by difficulties identifying and describing feelings and an externally oriented thinking style. A high rate of alexithymia is reported among patients with psychiatric and psychosomatic disorders. In this review, the authors examined the literature regarding the prevalence and importance of alexithymia in patients with neurological disorders. METHODS: A systematic search of the computerized databases MEDLINE and PubMed was conducted in order to identify papers on alexithymia in neurological disease...
2015: Journal of Neuropsychiatry and Clinical Neurosciences
https://read.qxmd.com/read/23781715/-present-and-future-of-the-transcranial-magnetic-stimulation
#10
REVIEW
Fidias E Leon-Sarmiento, Elías Granadillo, Edgardo A Bayona
Magnetic stimulation has called the attention of neuroscientists and the public due to the possibility to stimulate and "control" the nervous system in a non-invasive way. It has helped to make more accurate diagnosis, and apply more effective treatments and rehabilitation protocols in several diseases that affect the nervous system. Likewise, this novel tool has increased our knowledge about complex neural behavior, its connections as well as its plastic modulation. Magnetic stimulation applied in simple or paired-pulse protocols is a useful alternative in the diagnosis of diseases such as multiple sclerosis, Parkinson disease, epilepsy, dystonia, amyotrophic lateral sclerosis, cerebrovascular disease, and sleep disorders...
March 2013: Investigación Clínica
https://read.qxmd.com/read/16842141/hyperhomocysteinemia-in-movement-disorders-current-evidence-and-hypotheses
#11
JOURNAL ARTICLE
Stefano Zoccolella, Davide Martino, Giovanni Defazio, Paolo Lamberti, Paolo Livrea
Elevated plasma levels of homocysteine (Hcy) are a risk factor for systemic vascular diseases, stroke and vascular dementia. In recent years, increasing Hcy levels have been detected in neurological disorders that are not vascular in origin including Alzheimer's Disease and movement disorders (MD) such as idiopathic Parkinson's Disease (PD), Huntington's Disease (HD) and primary dystonia. Hyperhomocysteinemia (HHcy) in PD results from L-Dopa administration and its O-methylation dependent from catechol-O-methyltransferase and may be implicated in the development of motor complications and non-motor symptoms, such as dementia...
July 2006: Current Vascular Pharmacology
https://read.qxmd.com/read/11107559/-achievements-disappointments-and-hopes-in-neurological-therapy-in-the-20th-century
#12
JOURNAL ARTICLE
T M Domzał
Only in the second half of the 20th century a breakthrough occurred in the traditional neurological therapeutic methods based up to that time mainly on bromine with valerian extract and vitamins B. Later on in that century several great discoveries were made which improved greatly the effectiveness of the neurological therapy: psychopharmacology which began with the introduction of chlorpromazine and reserpine, the use of corticosteroids for which the Nobel award was given, levodopa introduction for Parkinson's disease, non-steroid antiinflammatory agents and the demonstration of their action mechanism /also Nobel award/, immunotherapy, botulin toxin for the treatment of dystonias and thrombolytic drugs possibly the drugs of the future...
1999: Neurologia i Neurochirurgia Polska
1
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.